FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns pharmaceutical industry, particularly means of cerebral cardiovascular disease treatment and prevention. Pharmaceutical composition for cerebral cardiovascular disease treatment and prevention includes definite steroid saponins in definie amount. Method of pharmaceutical composition preparation involves weighing furostanol saponin and spyrostanol saponin, mixing them at definite ratio, adding pharmaceutically acceptable adjuvants. Method of obtaining pharmaceutical composition involves cutting or breaking of rhizome of definite plants, extraction, extract filtering and passing through a column with absorbing resin, eluate disposal, column flushing with water, flush water disposal, column elution, eluate collection and concentration, adding alcohol to concentrated solution, filtrate collection after filtration, filtrate concentration and drying, adding pharmaceutically acceptable adjuvates. Pharmaceutical composition is applied in pharmaceutical medicine production for cerebral cardiovascular disease treatment and prevention.
EFFECT: highly stable composition efficient for cerebral cardiovascular disease treatment and prevention.
17 cl, 4 dwg, 8 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION , CONTAINING HERB COMBINATION EXTRACT, FOR PREVENTION OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY | 2011 |
|
RU2566721C2 |
| EXTRACT OF FAMILY DIOSCOREACEAE AND COMPOSITION FOR PREVENTING OR TREATING PERIPHERAL NEUROPATHY CONTAINING SAME | 2006 |
|
RU2430737C2 |
| COMPOSITION FOR PREVENTING OR TREATING PERIPHERAL NEUROPATHY | 2006 |
|
RU2453327C1 |
| COMPOSITION CONTAINING HERBAL EXTRACT FOR PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS | 2011 |
|
RU2575832C2 |
| METHOD OF PRODUCING TIMOSAPONIN BII | 2005 |
|
RU2395518C2 |
| NOVEL HELIOMYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF INHIBITING TUMOR GROWTH | 2018 |
|
RU2670763C1 |
| BACTERICIDAL AGENT AND BACTERICIDAL COMPOSITION | 2007 |
|
RU2414818C2 |
| NOVEL 5,7-DISUBSTITUTED [1,3]THIAZOLO[4,5-d]PYRIMIDINE-2-(3H)-AMINE DERIVATIVES AND USE THEREOF IN THERAPY | 2007 |
|
RU2437889C2 |
| NEW STEROID COMPOUNDS SHOWING HIGHER WATER SOLUBILITY AND METABOLISM RESISTANCE, AND METHODS FOR PREPARING THEM | 2007 |
|
RU2458065C2 |
| NEW 5,7-DISUBSTITUTED [1,3]THIAZOLO-[4,5-d]PYRIMIDIN-2(3H)-ONE DERIVATIVES AND THEIR APPLICATION IN THERAPY | 2007 |
|
RU2441012C2 |
